Okmetic Oyj - Company Announcement

Change in Okmetic's financial reporting

OKMETIC OYJ      STOCK EXCHANGE RELEASE  15 SEPTEMBER 2016      AT 9.45 A.M.


CHANGE IN OKMETIC'S FINANCIAL REPORTING

Okmetic Oyj ("Okmetic") announced earlier today that it has applied for the
termination of trading with and the delisting of its shares from Nasdaq Helsinki
Ltd conditional upon NSIG Finland S.à r.l. having gained ownership to all of the
issued and outstanding shares in Okmetic that are not owned by Okmetic or any of
its subsidiaries in the redemption proceedings concerning minority shares in
Okmetic in accordance with the Finnish Limited Liability Companies Act.

As a result of the minority share redemption proceedings and the application for
the termination of trading and the delisting of shares, the board of directors
of Okmetic has resolved that the company will not publish interim report Q3.
This marks a change to the financial reporting timetable announced earlier by
the company, according to which the company would publish an interim report Q3
on Thursday 27 October 2016. Pursuant to the amendment of the Finnish Securities
Markets Act that entered into force on 26 November 2015 listed companies are no
longer obliged to publish interim reports for the first three and nine months of
their financial periods.

OKMETIC OYJ

Kai Seikku
President

For further information, please contact:

Kai Seikku, President
Tel. +358 9 5028 0232, e-mail: kai.seikku@okmetic.com

Tapio Hyvärinen, CFO
Tel. +358 5028 0408, e-mail: tapio.hyvarinen@okmetic.com


Okmetic supplies tailored, high value-added silicon wafers to be used in the
manufacture of sensors as well as discrete semiconductors and analog circuits.
Okmetic's strategic objective is profitable growth driven by a product portfolio
designed to meet customers' current and future technology needs. The core of the
company's operations is being genuinely close to the customers and understanding
their needs and processes.

Okmetic's global sales network, extensive portfolio of high value-added
products, in-depth knowledge of crystal growing, long-term product development
projects, as well as efficient and flexible production create prerequisites for
achieving the strategic targets. The company's headquarters is located in
Finland, where the majority of the company's silicon wafers is manufactured. In
addition to in-house manufacture, Okmetic has contract manufacturing in Japan
and China. Okmetic's shares are listed on Nasdaq Helsinki Ltd under the code
OKM1V. For more information on the company, please visit our website at
www.okmetic.com.




[]

Priedai:

OKME3616_change in financial reporting.pdf